Director, Business Development, Therna Biosciences
Amir brings extensive experience in Pharma and Biotech, encompassing roles as a Technical Team Lead as well as in Strategy and Business Development (BD). His background includes leading discovery platforms at two Flagship Pioneering companies, Repertoire Immune Medicine and Sail Therapeutics. Additionally, he previously guided Corporate Development and External Innovation at Ceptur Therapeutics and successfully established Ginkgo Bioworks’ high-throughput PROPHET-Ab product. Consulting for early stage AI based protein therapeutics companies including Profluent Bio. Currently, Amir leads the BD and investor relations efforts at Therna Bio, an AI/ML RNA therapeutics company originating from a spin-out of the Goodarzi lab at UCSF/Arc Institute.